论文部分内容阅读
目的:对丹参川芎嗪联合依达拉奉治疗急性脑梗死的临床疗效进行分析。方法:选取我院就诊的脑梗塞急性期患者60例,分为实验组和对照组各30例,对照组给予西医常规治疗,实验组在西医常规治疗上给予丹参川芎嗪联合依达拉奉治疗。结果:经过治疗后,对比两组患者的治疗情况,实验组总有效率为96.66%,对照组总有效率为76.66%,P<0.05。结论:丹参川芎嗪联合依达拉奉治疗急性期脑梗塞能够有效改善神经功能缺损,提高治疗效果,值得在临床上大力推广。
Objective: To analyze the clinical efficacy of ligustrazine combined with edaravone in the treatment of acute cerebral infarction. Methods: 60 cases of acute cerebral infarction in our hospital were selected, which were divided into experimental group and control group, 30 cases in each group. The control group was treated with conventional western medicine. The experimental group was treated with ligustrazine plus edaravone . Results: After treatment, the total effective rate was 96.66% in the experimental group and 76.66% in the control group (P <0.05). Conclusion: Treating acute cerebral infarction with Ligustrazine tetramethylpyrazine combined with edaravone can effectively improve neurological deficit and improve the therapeutic effect, which is worth to be popularized clinically.